← Evidence map

ArticleJournal of viral hepatitis2012

Safety, pharmacokinetics and resistant variants of telaprevir alone for 12 weeks in hepatitis C virus genotype 1b infection.

I Yamada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

6 papers cite it

2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
this papertrialcites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 22239508